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Abstract— A 3-dimensional hemispheric computational brain
model is developed to simulate infusion of cold saline in the 
carotid arteries in terms of brain cooling for stroke therapy.
The model is based on the Pennes bioheat equation, with four
tissue layers: white matter, gray matter, skull, and scalp.  The
stroke lesion is simulated by reducing blood flow to a selected 
volume of the brain by a factor of one-third, and brain 
metabolism by 50%.  A stroke penumbra was also generated
surrounding the core lesion (blood volume reduction 25%,
metabolism reduction 20%).  The finite difference method was
employed to solve the system of partial differential equations.
This model demonstrated a reduction in brain temperature, at 
the stroke lesion, to 32 ˚C in less than 10 minutes.
I. INTRODUCTION
troke is a disease whose incidence exceeds 700,000 
new and recurrent cases each year in the United States, 
and contributes to over 250,000 deaths. In addition,
there are 5.5 million stroke survivors, many with persistent
neurological deficits [1].
Presently, the only FDA approved treatment for ischemic
stroke is tissue plasminogen activator (t-PA), a thrombolytic
drug administered intravenously.  However, a major risk of 
t-PA administration is intracerebral hemorrhage, and the 
treatment must be given within three hours of stroke onset to
maximize effectiveness and minimize the risk of
hemorrhage [2].
The incredibly narrow therapeutic window of t-PA in
stroke is generally attributed to, among other factors, the
high metabolic requirements of brain tissue [3]. When these
needs are not met, the tissue is quickly and irreversibly
damaged.  For this reason, hypothermia, which lowers brain
metabolism, has emerged as a potential alternative or
adjunct therapy to t-Pa. 
Hypothermia has demonstrated neuroprotection in cases
of cardiac arrest [4, 5].  Preliminary results of studies of
hypothermia in the setting of acute stroke have also
demonstrated the benefits of cooling [3].
Methods of inducing hypothermia are varied.  Whole
body surface cooling can be induced through through
cooling blankets, and/or alchohol [6].  Although these
methods are simple to employ, the time to reach target
temperature can exceed 6 hours [6], a time which exceeds 
the critical therapeutic window of 3 hours. Intravenous
cooling catheters can potentially induce hypothermia
througout entire body more quickly [7].  However, there
remain significant and serious complications associated with 
systemic hypothermia including infections, arrhythmias, and
coagulation disorders [3].
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Selective brain cooling (SBC), which circumvents many
of the complications of systemic hypothermia, is normally
induced with ice packs or cooling caps [8].  Theoretical 
analyses of surface SBC have revealed that cooling occurs 
in only the outer layer of brain gray matter [9].  Intracerebral 
temperature monitoring in surface SBC trials confirmed a 
very limited effect of this method [10].
One potential method of brain SBC is through intracarotid 
cold saline infusion (ICSI).  In this procedure, cold saline is 
infused into the internal carotid artery (ICA) via
transfemoral catheterization.  This method has actually been 
successfully attempted in cases of cardiac arrest [11].  This 
method would potentially be much faster than whole body
cooling and more effective than surface SBC. 
To evaluate the potential of intracarotid SBC, a
mathematical hemispheric model of the brain has been 
developed.  Temperature evolution in the brain is modeled
via the Pennes bioheat transfer equation [12].  Similar
models have been employed to evaluate surface SBC [9] and 
brain temperature in near drowning situations [13].
II. METHODS
A. Hemispheric Brain Model
The 3D hemispheric brain model (HBM) consisted of 4
layers: white matter, gray matter, bone, and scalp. Each
layer was given thermal and physiological constant values,
including heat conductivity, heat capacity, density,
metabolism, and perfusion, corresponding to the layer’s
physical and biological properties.  In addition, the radii of 
each of the layers of the HBM were set according to the 
geometry of an average adult human head.
Each of the layers was implemented on three dimensional
grids indexed, in spherical coordinates, by radius from
sphere center (r), azimuth angle (ș), and longitudinal angle
(I).  Fig. 1 demonstrates the implementation of the model.
B. Pennes Bioheat Transfer Model
Heat transfer through the HBM was based on the Pennes 
bioheat equation [12], expressed as:
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Fig. 1. Coronal view of hemispheric brain model and its tissue layers.  3D 
grids corresponding to each of the tissue layers are indexed by radius (r),
azimuth angle (ș), and longitudinal angle (I). r1-4 are the outer radii of each
of the tissue layers.  As indicated, the simulations utilized cold saline 
infusions on only one side.
where T is temperature, k is the tissue thermal conductivity,
ȡ is density, c is heat capacity, Z is blood perfusion, q is 
tissue metabolism, t is the time point, and x*  is the spatial
location .  The subscript “blood” signifies blood density and 
heat capacity while the subscript “artery” signifies arterial 
temperature (37˚ C without cold saline infusion). Tissue
variables and parameters lack a subscript.
This 4D partial differential equation was solved using
finite differences (three point central differences in space 
and two point forward differences in time) [14]. In spherical
coordinates, the diffusion term of equation (1) is expressed
as follows:




































C. Boundary Conditions 
There are basically three physical boundary conditions 
implied by this model:  the base of the brain (hemisphere),
the surfaces between tissue layers, and the outer surface of
the scalp. 
An adiabatic (i.e. insulated) boundary condition is 
assumed for the bottom of the brain according to other 






For the boundary between tissue layers, the following
















21 TT  (5)
where the subscripts “1” and “2” refer to two different tissue
layers.
The following equation describes the boundary condition 





where hair is the heat transfer coefficient between the head
and air and is equal to 8 W/(m2 . K) [9]. Tair is the
temperature of air (25 ˚C).
D. Metabolic and Perfusion Changes with Temperature
and Hematocrit
Hypothermia is known to decrease both metabolism (q)
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where Z0 and q0 are baseline perfusion and metabolism for
either gray or white matter.
Note that because of coupling of metabolism and 
perfusion believed to occur in humans and demonstrated to
exist in animals [16], the values of Į and ȕ are assumed to be 
the same for these two relations.
To determine the values of Į and ȕ, data was pooled
together from various human and animal studies of
hypothermia [17-19]. This data was fit to (3) using
unconstrained nonlinear optimization [20] resulting in
values of D = 3.0 and E = 0.08 (RMSE = 19%). 
Similarly, there is a nearly linear relationship between
brain perfusion and hematocrit described by the relation:
 HCT' JZZ 10 (9)
To determine the value of Ȗ, data was pooled together
from various human studies of normovolemic and “Triple
H” hemodilution [21, 22].  The data was fit to (5) using
linear least-squares fitting resulting in a value of Ȗ = 2.2 
(RMSE = 5.3%). 
Combining (3) and (5) yielded a relationship for
combined hematocrit and temperature changes which was 
used for modeling purposes. 
  HCTT '  2.210.3 37084.00ZZ  (10) 
E. ICA Perfusion Territory 
Since the model involves a unilateral intracarotid saline 
infusion, there are two regions of significance in the model:
the region perfused by the ipsilateral ICA, and the rest of the
model (note that the model assumes that the perfusion
regions are non-overlapping).
Geometrically, the ipsilateral ICA region occupies only
one side of the model (conventionally the right side).
Further, the rear 30˚ of the ipsilateral side of the brain is
perfused by the posterior circulation (i.e. vertebral arteries).
Therefore, the ICA territory of the model is described by:
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F. Temperature and Hematocrit changes with Infusion
A cold saline infusion into the intracarotid artery will both 






































where Tp and HCTp is, respectively, the temperature and 
hematocrit of the perfusate (cold saline mixed with blood).
HCT is the systemic hematocrit.
The ICA blood flow is determined by integrating the
perfusion map within the region described by (11):
³³³ 
TerritoryICA
dVFlowBloodICA Z  (14) 
The systemic hematocrit, HCT, changes with infusion of










where VRBC (2.1 L) is the red blood cell volume, VIV0 (5 L) 
is the initial intravascular volume, ǻVIV is the volume of 
added saline, and p is the fraction of extracellular body
water that is intravascular.
In steady state, p is normally between 0.25 and 0.33. 
However, since therapy will take place over short periods of 
time relative to the time for intravascular volume to reach 
equilibrium, p should be somewhat higher in practice. To
determine a working value of p, (15) was fit with data from
hypervolemic hemodilution studies [23, 24] by
unconstrained nonlinear optimization [20], yielding p=0.42
(RMSE=0.014).
G. Stroke Model
An ischemic volume, with both stroke core and ischemic
penumbra, was created within the ICA perfusion region, in
both gray and white matter, according to the following angle 
demarcations: Stroke core (ș = 16o – 54o; I = 37.5o – 52.5o);
ischemic penumbra (ș = 18o – 36o and 54o – 72o; I = 15o – 
37.5o and 52.5o – 75o). The total stroke volume was 136.4 
ml and the volume of the core was 11.87 ml.
During ischemia, blood perfusion and metabolic rate in
the ischemic core were reduced to 25% and 30% of their 
normal values, respectively. Blood perfusion and metabolic
rate were reduced to 40% and 50%, respectively, in the
evolving infarct (ischemic penumbra). These reductions in
metabolic rate and perfusion are close to the ones reported in
the literature.
III. RESULTS
Fig. 2 demonstrates the temperature distribution in a V-
shaped trajectory through the brain (passing through the
stroke core) after 1 hour of freezing-cold saline infusion at
different rates. The simulation demonstrates that the
temperature can decrease to as low as 28 ˚C at the gray-
white matter boundary with an infusion of 50 ml/min.
Fig. 3 demonstrates the temporal temperature profile of a
point (r = 74.2 mm, ș = 22.5˚, and I = 63˚) in the stroke
penumbra (the area of the stroke volume most amenable to
therapy) over a one hour period, for a variety of freezing-
cold saline infusion rates.  The temperature decreases most
quickly during the first 10 minutes, easily reaching a target 
hypothermia temperature of 32 ˚C [6] for both the 40 and 50 
ml/min infusion rates.  Note a gradual increase in the
temperatures after reaching a minimum at ~15 min caused 
by hemodilution increasing warm blood flow through the
ICA.
Fig. 2. Radial temperature distribution, 60 min after different rates of saline 
infusion in a brain with stroke. Temperature was sampled along line AB
(dashed). The V-shaped line AB starts at a latitude of 45o, descends to the 
center-base of the brain and ascends back to the same latitude, in a 
longitudinal plane from -135˚ to +45˚. The longitudinal plane dissects 
through the posterior circulation territory of the contralateral hemisphere to 
the anterior territory of the ipsilateral hemisphere, via the center of the 
brain.  Note that line AB passes through the stroke core.  Solid bold line (0/
ml/min) represents brain temperature before infusion.
Fig. 4 tracks the hematocrit changes in both the systemic
blood and the perfusate which feeds the ipsilateral ICA
territory of the brain.  Over the course of an hour, the
systemic hematocrit always remained above 30%.  The 
hematocrit of the perfusate decreased to a minimum of 25%
after 1 hour of infusion.
IV. CONCLUSIONS
This study demonstrates the potential of quickly and 
effectively inducing selective hypothermia in the brain
through ICSI.  Target temperatures of ~34 or ~32 ˚C can be 
induced with flow rates of respectively 20 or 30 ml/min. In
addition, these temperatures can be quickly induced in less
than 10 minutes with an infusion of 40 ml/min.
Although infusion times of 1 hour appear safe, as
cardiopulmonary bypass operations have established the
safety of hematocrit values in the low 20s [25], the
hemodilution effect of this procedure would limit the length
of time it could be employed.  Other than possibly
lengthening the therapeutic window of t-PA or mechanical
removal of the thrombosis, this procedure could also be used 




















































as an adjunct to systemic hypothermia, immediately
lowering brain temperature to its therapeutic target while the
rest of the body is in its slower process of cooling.
Fig. 3. Brain temperatures in stroke penumbra over one hour sampling
period.  The sampling point was r = 74.2 mm, ș = 22.5˚, and I = 63˚.
Fig. 4. Systemic and local (i.e. ICA perfusate) hematocrit over the course of 
a one hour infusion for a variety of saline flow rates.
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